New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-09
DOI
10.3389/fphar.2019.00363
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine
- (2018) Heike Israel et al. Current Pain and Headache Reports
- The CGRP Pathway in Migraine as a Viable Target for Therapies
- (2018) Lars Edvinsson HEADACHE
- Migraine is first cause of disability in under 50s: will health politicians now take notice?
- (2018) Timothy J. Steiner et al. JOURNAL OF HEADACHE AND PAIN
- The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system
- (2018) Karl Messlinger JOURNAL OF HEADACHE AND PAIN
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks
- (2018) Anne Luise H. Vollesen et al. JAMA Neurology
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries
- (2018) Lena Ohlsson et al. JOURNAL OF HEADACHE AND PAIN
- Emerging drugs for migraine treatment: an update
- (2018) Giorgio Lambru et al. EXPERT OPINION ON EMERGING DRUGS
- CGRP, Amylin, Immunology, and Headache Medicine
- (2018) Frederick R. Taylor HEADACHE
- Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies
- (2018) Stefanie Förderreuther et al. JOURNAL OF HEADACHE AND PAIN
- Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Lars Jacob Stovner et al. LANCET NEUROLOGY
- Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events
- (2017) Mônica Simon Prado et al. Expert Opinion on Drug Metabolism & Toxicology
- Blocking CGRP in migraine patients – a review of pros and cons
- (2017) Marie Deen et al. JOURNAL OF HEADACHE AND PAIN
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathophysiology of Migraine: A Disorder of Sensory Processing
- (2017) Peter J. Goadsby et al. PHYSIOLOGICAL REVIEWS
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
- (2017) David Monteith et al. Frontiers in Pharmacology
- Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab
- (2017) Maria Giamberardino et al. Journal of Pain Research
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis
- (2016) Robin M van Dongen et al. CEPHALALGIA
- CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
- (2015) Lars Edvinsson BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Targeting TRP Channels For Novel Migraine Therapeutics
- (2014) Gregory Dussor et al. ACS Chemical Neuroscience
- Emerging drugs for migraine treatment
- (2014) Maria Adele Giamberardino et al. EXPERT OPINION ON EMERGING DRUGS
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
- (2013) Sajedeh Eftekhari et al. JOURNAL OF PAIN
- Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity
- (2013) Dimitris N. Xanthos et al. NATURE REVIEWS NEUROSCIENCE
- Sumatriptan Inhibits TRPV1 Channels in Trigeminal Neurons
- (2012) Miles Steven Evans et al. HEADACHE
- Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
- (2012) Tony W. Ho et al. HEADACHE
- Prophylaxis of migraine: general principles and patient acceptance
- (2011) Domenico D'Amico et al. Neuropsychiatric Disease and Treatment
- Regulation of signal transduction by calcitonin gene-related peptide receptors
- (2010) Christopher S Walker et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics of Immunoglobulin Administered via Intravenous or Subcutaneous Routes
- (2008) Francisco A. Bonilla IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now